Hospitalized patient calls for changes to MS election laws. She wants to vote but can't
The No. 1 thing on Nancy Oliver's mind is Tuesday's presidential election between Vice President Kamala Harris and former ...
Managed Healthcare Executive4d
The Takeaway From Study of Midlife MS Patients: Don't Stop Disease-Modifying Therapy
and SPMS represents the later stages of MS. MS is typically diagnosed between the ages of 20 and 40 years, and patients usually progress from RRMS to SPMS around the age of 50. As the disease ...
Multiple Sclerosis News Today2d
Study IDs 2 enzymes that mediate toxic effects of saturated fats in MS
Two enzymes in brain cells are responsible for mediating the toxic effects of certain fat molecules in multiple sclerosis, ...
Johns Hopkins Newsletter1d
Amber Salter speaks on comorbidities and outcomes in multiple sclerosis research
On Tuesday, Nov. 5, as part of the Johns Hopkins Medicine’s Department of Neurology and Neurosurgery Neuroimmunology Seminar Series, Dr. Amber Salter delivered an overview of her ongoing work ...
MedPage Today7d
Year in Review: Multiple Sclerosis
"Thus, progression is present in most, if not all, patients with multiple sclerosis, regardless of where they are in the ...
The American Journal of Managed Care6d
Exploring Metabolic Links to Cognitive Impairment in MS
The complex relationship between possibly impaired cognitive function in patients with multiple sclerosis (MS) and fasting ...
'It's a miracle': Stem cell treatment offers hope for MS patients
Doctors at Jewish Hospital Mercy Health are pioneering a new approach to treating multiple sclerosis (MS), offering hope to ...